[THE EFFECT OF BLOOD SUGAR CHANGES ON INTERMEDIATE METABOLISM IN PATIENTS WITH ASTHENIC NEUROSES. II. EFFECT OF  TREATMENT WITH INCREASING DOSES OF INSULIN].
D000596:Amino Acids; D001247:Asthenia; D001714:Bipolar Disorder; D001786:Blood Glucose; D002951:Citrates; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin; D007656:Ketoglutaric Acids; D001523:Mental Disorders; D008660:Metabolism; D009440:Neurasthenia; D009497:Neurotic Disorders; D009584:Nitrogen; D011618:Psychotic Disorders; D011773:Pyruvates
D000596:Amino Acids; D001786:Blood Glucose; D002951:Citrates; D007328:Insulin; D007656:Ketoglutaric Acids; D011773:Pyruvates; D009584:Nitrogen
AMINO ACIDS; BLOOD SUGAR; CITRATES; GLUCOSE TOLERANCE TEST; INSULIN; KETOGLUTARIC ACID; METABOLISM; NEURASTHENIA; NITROGEN; PSYCHOSES, MANIC-DEPRESSIVE; PYRUVATES
DIE WIRKUNG DER GLYKAEMIEAENDERUNG AUF DEN INTERMEDIAERSTOFFWECHSEL BEI  PATIENTEN MIT ASTHENISCHER NEUROSE. II. WIRKUNG DER BEHANDLUNG MIT ZUNEHMENDEN INSULINDOSEN.